Detalhe da pesquisa
1.
Hidden in plain sight - Survival consequences of baseline symptom burden in women with recurrent ovarian cancer.
Gynecol Oncol
; 185: 128-137, 2024 Feb 26.
Artigo
em Inglês
| MEDLINE | ID: mdl-38412736
2.
Measure of Ovarian Symptoms and Treatment concerns (MOST) indexes and their associations with health-related quality of life in recurrent ovarian cancer.
Gynecol Oncol
; 166(2): 254-262, 2022 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-35718565
3.
Symptom burden and quality of life with chemotherapy for recurrent ovarian cancer: the Gynecologic Cancer InterGroup-Symptom Benefit Study.
Int J Gynecol Cancer
; 32(6): 761-768, 2022 06 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-35086926
4.
A qualitative analysis and development of a conceptual model assessing financial toxicity in cancer patients accessing the universal healthcare system.
Support Care Cancer
; 29(6): 3219-3233, 2021 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-33094357
5.
Measuring what matters MOST: validation of the Measure of Ovarian Symptoms and Treatment, a patient-reported outcome measure of symptom burden and impact of chemotherapy in recurrent ovarian cancer.
Qual Life Res
; 27(1): 59-74, 2018 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-29248998
6.
A systematic review of patient-reported outcome instruments of dermatologic adverse events associated with targeted cancer therapies.
Support Care Cancer
; 23(8): 2231-44, 2015 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-25564221
7.
Gynecologic Cancer InterGroup (GCIG) consensus review for clear cell carcinoma of the uterine corpus and cervix.
Int J Gynecol Cancer
; 24(9 Suppl 3): S90-5, 2014 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-25341588
8.
Gynecologic Cancer InterGroup (GCIG) consensus review for clear cell carcinoma of the ovary.
Int J Gynecol Cancer
; 24(9 Suppl 3): S20-5, 2014 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-25341576
9.
Cancer-related fatigue in Italian cancer patients: validation of the Italian version of the Brief Fatigue Inventory (BFI).
Support Care Cancer
; 21(2): 413-9, 2013 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-22790224
10.
Clinical practice guidelines for the prevention and treatment of acute and late radiation reactions from the MASCC Skin Toxicity Study Group.
Support Care Cancer
; 21(10): 2933-48, 2013 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-23942595
11.
Roadmap for the European Network of Gynaecological Trial groups (ENGOT) Trials.
Int J Gynecol Cancer
; 23(7): 1339-43, 2013 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-23970159
12.
Cultural adaptation of the Italian version of the Patient-Reported Outcomes Common Terminology Criteria for Adverse Event (PRO-CTCAE®).
Tumori
; 109(3): 324-334, 2023 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-35674125
13.
Inhibition of stromal CXCR4 impairs development of lung metastases.
Cancer Immunol Immunother
; 61(10): 1713-20, 2012 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-22399057
14.
Gefitinib in non small cell lung cancer.
J Biomed Biotechnol
; 2011: 815269, 2011.
Artigo
em Inglês
| MEDLINE | ID: mdl-21660144
15.
Clinical practice guidelines for the prevention and treatment of EGFR inhibitor-associated dermatologic toxicities.
Support Care Cancer
; 19(8): 1079-95, 2011 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-21630130
16.
Italian ethical committee intervention in a case of embryo-fetal medicine.
Med Law
; 30(2): 201-14, 2011 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-21877466
17.
Cross-sectional study to develop and describe psychometric characteristics of a patient-reported instrument (PROFFIT) for measuring financial toxicity of cancer within a public healthcare system.
BMJ Open
; 11(10): e049128, 2021 10 20.
Artigo
em Inglês
| MEDLINE | ID: mdl-34670762
18.
Vandetanib (ZD6474), a dual inhibitor of vascular endothelial growth factor receptor (VEGFR) and epidermal growth factor receptor (EGFR) tyrosine kinases: current status and future directions.
Oncologist
; 14(4): 378-90, 2009 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-19349511
19.
Development and validation of a patient-reported outcome tool to assess cancer-related financial toxicity in Italy: a protocol.
BMJ Open
; 9(9): e031485, 2019 09 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-31501130
20.
Guidance Statement On BRCA1/2 Tumor Testing in Ovarian Cancer Patients.
Semin Oncol
; 44(3): 187-197, 2017 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-29248130